InsiderTrades

Form 4 for TMCI TREACE MEDICAL CONCEPTS, INC.

Accepted 2026-01-23 00:00:00 ET · period of report 2026-01-21 · accession 0001193125-26-021450 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-01-23 2026-01-22 TMCI Scanlan Sean F. Chief Innovation Off A - Grant $0.00 +262.5K 689.6K +61% $0
D 2026-01-23 2026-01-21 TMCI Scanlan Sean F. Chief Innovation Off M - OptEx $0.72 +53.5K 427.1K +14% +$38.5K
D 2026-01-23 2026-01-21 TMCI Scanlan Sean F. Chief Innovation Off M - OptEx $0.00 +53.5K 0 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-01-22 A A 262,500 $0.00 689,599 D — — (F2) Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 22, 2027 and the last installment vesting on January 22, 2030; subject to Reporting Person's providing continued service to Issuer through each vesting date. (F3) Includes 511,291 restricted stock units
2 Common Common Stock 2026-01-21 M A 53,500 $0.72 427,099 D — — (F1) Includes 283,948 restricted stock units.
3 Derivative Stock Option (Right to Buy) 2026-01-21 M A 53,500 $0.00 0 D $0.72 · 2020-01-26 to 2026-01-26 53,500 Common Stock (F4) The stock option vested in equal annual installments over 4 years, commencing on January 26, 2016 with the last installment vesting on January 26, 2020.